Maintenance Chemotherapy with S-1 Following SOX Regimen Chemotherapy Improves Prognosis of Stage 3 Gastric Cancer After D2 Gastrectomy: A 5-Year Analysis
Chengwu Tang, Wenming Feng, Ying Bao, Cheng Chen Department of General Surgery, First People’s Hospital Affiliated to Huzhou Normal College, Huzhou, People’s Republic of ChinaCorrespondence: Cheng Chen Department of General SurgeryFirst People’s Hospital Affiliated to H...
Main Authors: | Tang C, Feng W, Bao Y, Chen C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/maintenance-chemotherapy-with-s-1-following-sox-regimen-chemotherapy-i-peer-reviewed-article-OTT |
Similar Items
-
Outcomes of gastrectomy following upfront chemotherapy in advanced gastric cancer patients with a single noncurable factor: a cohort study
by: Li W, et al.
Published: (2019-03-01) -
Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
by: Yanrui Liang, et al.
Published: (2021-02-01) -
An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer
by: Mikito Mori, et al.
Published: (2018-12-01) -
Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
by: Rebekka Schirren, et al.
Published: (2020-08-01) -
Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy
by: Chen L, et al.
Published: (2017-08-01)